Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check6 days agoChange DetectedA minor interface/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the page’s release/versioning rather than any study-record details.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision (v3.5.0) was added to the record history, and an older revision (v3.4.3) was removed. This is a metadata/version-history change rather than an update to trial content.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed from the history.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the Study Record History; this routine site-release change does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history now shows Revision: v3.4.1, replacing Revision: v3.4.0. This is a minor metadata update to the page.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.